Innate immunology

Ossip Groth (Diskussion | Beiträge)
(Die Seite wurde neu angelegt: „ {{ttp|p=32291557|t=ä. SARS-CoV-2-encoded nucleocapsid protein acts as a viral suppressor of RNA interference in cells |pdf=|usr=}} {{tp|p=32198201|t=2020. Co…“)

---

Aktuelle Version vom 9. Juli 2020, 06:15 Uhr

32291557 ä. SARS-CoV-2-encoded nucleocapsid protein acts as a viral suppressor of RNA interference in cells

32198201 2020. Coronavirus endoribonuclease targets viral polyuridine sequences to evade activating host sensors
32374430 2020. DC/L-SIGNs of Hope in the COVID-19 Pandemic
32361001 ä. Bioinformatic analysis and identification of single-stranded RNA sequences recognized by TLR7/8 in the SARS-CoV-2, SARS-CoV, and MERS-CoV genomes
32248387 ä. Use of DAMPs and SAMPs as Therapeutic Targets or Therapeutics: A Note of Caution

32407669 ä. Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients

32456409 2020. A theory on SARS-COV-2 susceptibility: reduced TLR7-activity as a mechanistic link between men, obese and elderly.

32156572 2020. Viroporins and inflammasomes: A key to understand virus-induced inflammation

32454408 2020. COVID-19 as a STING disorder with delayed over-secretion of interferon-beta.

32524333 2020. COVID 19: a clue from innate immunity.
32464098 2020. The Innate Immune System: Fighting on the Front Lines or Fanning the Flames of COVID-19?

32599245 2020. Targeting hub genes and pathways of innate immune response in COVID-19: A network biology perspective.

32574272 2020. Innate Immune Signaling and Proteolytic Pathways in the Resolution or Exacerbation of SARS-CoV-2 in Covid-19: Key Therapeutic Targets?